To elucidate the mechanism by which NPFFR2 increases cancer malignancy, we analyzed the expression of representative downstream signaling proteins activated by GPCR signaling in NPFFR2–depleted or NPFF–treated cells. This evidence concerns the gene NPFFR2 and cancer.